Biotech

All Articles

Novo inks $600M NanoVation offer to analyze hereditary drugs ex-liver

.Novo Nordisk is proceeding its push right into genetic medications, accepting to pay NanoVation The...

Innovent hyperlinks cytokine to intestines cancer cells feedbacks

.Innovent Biologics has actually created the situation that its own checkpoint inhibitor-cytokine bl...

Merck, Daiichi ADC reaches target in phase 3 lung cancer research

.A period 3 trial of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate ...

Rakovina grows AI center along with collab to pick cancer cells targets

.5 months after Rakovina Rehabs pivoted toward artificial intelligence, the cancer-focused biotech h...

Ascendis' dwarfism drug hits in phase 3, threatens BioMarin

.Ascendis Pharma has become a potential danger to BioMarin's Voxzogo, stating phase 3 growth problem...

Despite ph. 3 miss out on, Alkeus views pathway in advance for eye health condition property

.Though Alkeus Pharmaceuticals' dental eye condition asset neglected to dramatically decrease geogra...

Kairos goes social along with $6M IPO to cash tests of cancer medicine

.Along with a trio of biotechs hitting the Nasdaq on Friday, it was actually quick and easy to overl...

Vaccine and Keytruda combo successful in squamous cell cancer

.Immune system checkpoint preventions are actually the superheroes of cancer cells treatment. Medica...

Cue Biopharma queues up J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of notable leadership hirings, shootings and als...

Regeneron's Opdualag competitor presents 57% action cost

.Regeneron is back with long-term consequence for its own LAG-3 prevention and PD-1 inhibitor combin...